[{"Assets_0_Q3_USD":4582048000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-9421000.0,"NetIncomeLoss_1_Q3_USD":6888000.0,"NetIncomeLoss_2_Q3_USD":-32331000.0,"NetIncomeLoss_3_Q3_USD":-10976000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":128222000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":127196000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":127247000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":127196000.0,"StockholdersEquity_0_Q3_USD":501105000.0,"EarningsPerShareBasic_1_Q3_USD":0.05,"EarningsPerShareBasic_3_Q3_USD":-0.1,"EarningsPerShareDiluted_1_Q3_USD":0.05,"EarningsPerShareDiluted_3_Q3_USD":-0.1,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":476487000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":1165463000.0,"Ticker":"AMRX","CIK":"1723128","name":"AMNEAL PHARMACEUTICALS, INC.","OfficialName":"Amneal Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"632684518.0","Country":"nan","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20181107"}]